SecBot SecBot
SECBOTREPLAY Home › Report › KALV

KALV · Multiple C-suite executives at KalVista Pharmaceuticals (KALV) sold…

KalVista Pharmaceuticals, Inc. · CLUSTER filed Feb 22, 2026 at 19:00 ET

At the news

BEARISHIMPACT 7/10

CLUSTER filed Feb 22, 2026 at 19:00 ET

Multiple C-suite executives at KalVista Pharmaceuticals (KALV) sold shares in a coordinated cluster over the past week, including the CEO, CFO, CMO, CDO, and CCO, realizing nearly $400K in total proceeds. The sales coincide with recent market activity showing insider selling pressure, raising concerns about near-term prospects despite no disclosed material events.

  • CEO Palleiko sold $156,197 worth of shares, the largest individual sale in the cluster.
  • All five C-suite executives participated in sales, totaling $396,600 in realized value.
  • Concurrent with share sales, insiders also exercised stock options (marketed transactions, 'M') for 49,500 shares at $0 cost, indicating option monetization.
  • No insider buying was observed, all activity was selling or option exercise.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access